Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.

Julien CALDERARO, F Petitprez, E Becht, A Laurent, TZ Hirsch, Benoit ROUSSEAU, Alain LUCIANI, Giuliana AMADDEO, J Derman, C Charpy, J Zucman-Rossi, WH Fridman, C Sautes-Fridman,

J Hepatol. 11/09/2018;pii: S0168-8278(18) : 32373-0 10.1016/j.jhep.2018.09.003

[Genealogy of lymph node and visceral metastases in colorectal cancer: "sisters" or "cousins"?]

Benoit ROUSSEAU, J Vibert,

Bull Cancer. 01/09/2018;105(9) : 737-739 10.1016/j.bulcan.2018.07.003 24/08/2018

Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma.

Benoit ROUSSEAU, A Guillemin, C Duvoux, C Neuzillet, C Tlemsani, P Compagnon, D Azoulay, C Salloum, A Laurent, A de la Taille, L Salomon, I Cholley, C Haioun, J Dupuis, P Wolkenstein, MB Matignon, P Grimbert, C Tournigand,

Int J Cancer 28/08/2018;- : - 10.1002/ijc.31769

Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives.

A Schernberg, E Rivin Del Campo, Benoit ROUSSEAU, O Matzinger, M Loi, P Maingon, F Huguet,

Clin Transl Radiat Oncol. 13/03/2018;10 : 13-22 10.1016/j.ctro.2018.02.005 01/03/2018

Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma

A Vienot, G Beinse, A Louvet, L de Mestier, A Meurisse, F Fein, B Heyd, D Cleau, C d'Engremont, AC Dupont-Gossart, Z Lakkis, C Tournigand, O Bouché, Benoit ROUSSEAU, C Neuzillet, F Bonnetain, C Borg, D Vernerey,

J Natl Cancer Inst. 01/10/2017;109(10) : . 10.1093/jnci/djx037.

Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017

C Costentin, N Ganne-Carrie, Benoit ROUSSEAU, R Gerolami, JC Barbare,

Bull Cancer 01/09/2017;104(9) : 752-761 10.1016/j.bulcan.2017.06.008 24/07/2017

Therapeutic drug monitoring - 4th edition of the congress of pharmacology of anticancer drugs

M Allard, Benoit ROUSSEAU, E Cardoso, A Bellesoeur, B Blanchet,

Bull Cancer 01/09/2017;104(9) : 800-806 10.1016/j.bulcan.2017.06.006. 27/07/2017

Therapeutic drug monitoring - 4th edition of the congress of pharmacology of anticancer drugs

M Allard, Benoit ROUSSEAU, E Cardoso, A Bellesoeur, B Blanchet,

Bull Cancer. 01/09/2017;104(9) : 800-806 10.1016/j.bulcan.2017.06.006. 27/07/2017

Simultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC-MS/MS

M Allard, N Khoudour, Benoit ROUSSEAU, C Joly, C Costentin, B Blanchet, C Tournigand, A Hulin,

J Pharm Biomed Anal. 05/08/2017;142 : 42-48 10.1016/j.jpba.2017.04.053 01/05/2017

Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumours

C Neuzillet, L de Mestier, Benoit ROUSSEAU, O Mir, M Hebbar, HM Kocher, P Ruszniewski, C Tournigand,

Pharmacol Ther. 16/07/2017;pii: S0163-7258(17) : 30166-3 10.1016/j.pharmthera.2017.07.006